Indian pharmaceutical giants, Dr. Reddy's Labs and Mankind Pharma, reported impressive double-digit revenue growth in the September quarter. Dr. Reddy's achieved this milestone despite challenges in Europe and increased expenses, while Mankind Pharma thrived on robust domestic sales and expansion into consumer healthcare. Both companies remain optimistic about future prospects.
